Jennifer Dumoulin
Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris-Saclay(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Ambroise-Paré(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Pneumonia and Respiratory Infections, Respiratory viral infections research, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort(2014)186 cited
- → Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab(2018)172 cited
- → Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial(2021)156 cited
- → Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges(2017)111 cited
- → Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab(2019)96 cited
- → Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer